Skip to main content
Industry News
Pfizer says COVID-19 vaccine effective in young teens

The Pfizer/BioNTech COVID-19 vaccine was safe and effective in 12- to 15-year-olds in a clinical trial, and the companies will seek emergency use authorization for the age group, Pfizer CEO Albert Bourla announced.

Full Story: